These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36927502)

  • 41. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Validation of the 2019 European League Against Rheumatism/American College of Rheumatology Criteria Compared to the 1997 American College of Rheumatology Criteria and the 2012 Systemic Lupus International Collaborating Clinics Criteria in Pediatric Systemic Lupus Erythematosus.
    Ma M; Hui-Yuen JS; Cerise JE; Iqbal S; Eberhard BA
    Arthritis Care Res (Hoboken); 2020 Nov; 72(11):1597-1601. PubMed ID: 31478595
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [New perspectives in the classification and treatment of systemic lupus erythematosus: the central role of kidney involvement].
    Cavagna L; Scorletti E; Romano M; Cagnotto G; Caporali R
    G Ital Nefrol; 2013; 30(4):. PubMed ID: 24403199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lupus nephritis is associated with more corticosteroid-associated organ damage but less corticosteroid non-associated organ damage.
    Joo YB; Won S; Choi CB; Bae SC
    Lupus; 2017 May; 26(6):598-605. PubMed ID: 27687027
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Self-Reported Physical Activity Is Associated with Lupus Nephritis in Systemic Lupus Erythematosus: Data from KORean Lupus Network (KORNET) Registry.
    Kim SK; Choe JY; Lee SS
    Yonsei Med J; 2018 Sep; 59(7):857-864. PubMed ID: 30091319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival.
    Min HK; Lee JH; Jung SM; Lee J; Kang KY; Kwok SK; Ju JH; Park KS; Park SH
    Korean J Intern Med; 2015 Mar; 30(2):232-41. PubMed ID: 25750566
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic lupus erythematosus in Tunisia: demographic and clinical analysis of 100 patients.
    Houman MH; Smiti-Khanfir M; Ben Ghorbell I; Miled M
    Lupus; 2004; 13(3):204-11. PubMed ID: 15119551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of the Systemic Lupus International Collaborating Clinics classification criteria in a cohort of patients with full house glomerular deposits.
    Rijnink EC; Teng YKO; Kraaij T; Dekkers OM; Bruijn JA; Bajema IM
    Kidney Int; 2018 Jan; 93(1):214-220. PubMed ID: 28950993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Systemic lupus erythematosus].
    Aringer M; Schneider M
    Internist (Berl); 2021 Apr; 62(4):385-396. PubMed ID: 33512549
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systemic lupus erythematosus among male patients in Malaysia: how are we different from other geographical regions?
    Shaharir SS; Kadir WDA; Nordin F; Bakar FA; Ting MWH; Jamil A; Mohd R; Wahab AA
    Lupus; 2019 Jan; 28(1):137-144. PubMed ID: 30458692
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Using a Multi-Institutional Pediatric Learning Health System to Identify Systemic Lupus Erythematosus and Lupus Nephritis: Development and Validation of Computable Phenotypes.
    Wenderfer SE; Chang JC; Goodwin Davies A; Luna IY; Scobell R; Sears C; Magella B; Mitsnefes M; Stotter BR; Dharnidharka VR; Nowicki KD; Dixon BP; Kelton M; Flynn JT; Gluck C; Kallash M; Smoyer WE; Knight A; Sule S; Razzaghi H; Bailey LC; Furth SL; Forrest CB; Denburg MR; Atkinson MA
    Clin J Am Soc Nephrol; 2022 Jan; 17(1):65-74. PubMed ID: 34732529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pattern of systemic lupus erythematosus in NIGERIA: a multicentre descriptive hospital-based study.
    Osaze O; Olaosebikan HB; Yerima A; Uhunmwangho CU; Ima-Edomwonyi UE; Oguntona AS; Chibuzo OC; Dedeke IA; Na'isa MBK; Nwankwo HM; Agun-Ebreme M; John-Maduagwu OJ; Ekeigwe NL; Adenitan A; Emorinken A; Odunlami GJ; Uchechukwu T; Augie AI; Abdul'Aziz U; Adelowo O
    Clin Rheumatol; 2023 Oct; 42(10):2787-2797. PubMed ID: 37338743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Performances of the ACR 1997, SLICC 2012, and EULAR/ACR 2019 Classification Criteria in Pediatric Systemic Lupus Erythematosus.
    Batu ED; Akca UK; Kısaarslan AP; Sağ E; Demir F; Demir S; Çiçek SÖ; Poyrazoglu H; Sozeri B; Bilginer Y; Ozen S
    J Rheumatol; 2021 Jun; 48(6):907-914. PubMed ID: 33191281
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disease-associated and patient-specific immune cell signatures in juvenile-onset systemic lupus erythematosus: patient stratification using a machine-learning approach.
    Robinson GA; Peng J; Dönnes P; Coelewij L; Naja M; Radziszewska A; Wincup C; Peckham H; Isenberg DA; Ioannou Y; Pineda-Torra I; Ciurtin C; Jury EC
    Lancet Rheumatol; 2020 Aug; 2(8):e485-e496. PubMed ID: 32818204
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus.
    Brunner HI; Mueller M; Rutherford C; Passo MH; Witte D; Grom A; Mishra J; Devarajan P
    Arthritis Rheum; 2006 Aug; 54(8):2577-84. PubMed ID: 16868980
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients.
    Fu Q; Chen X; Cui H; Guo Y; Chen J; Shen N; Bao C
    Arthritis Res Ther; 2008; 10(5):R112. PubMed ID: 18793417
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparing longitudinal patient-reported outcome measures between Swedish patients with recent-onset systemic lupus erythematosus and early rheumatoid arthritis.
    Heijke R; Björk M; Thyberg I; Kastbom A; McDonald L; Sjöwall C
    Clin Rheumatol; 2022 May; 41(5):1561-1568. PubMed ID: 34839415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
    Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
    Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Systemic lupus erythematosus].
    Aringer M; Schneider M
    Hautarzt; 2021 Apr; 72(4):337-348. PubMed ID: 33740079
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life.
    Pettersson S; Lövgren M; Eriksson LE; Moberg C; Svenungsson E; Gunnarsson I; Welin Henriksson E
    Scand J Rheumatol; 2012 Oct; 41(5):383-90. PubMed ID: 22646821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.